Abstract
Microorganism live inside the human body and thus the human are inimitable reservoir for diverse and vibrant group of microbes . These microbial species primarily modulates the host internal environment for the edification in the host health. This spectacular symbiotic relationship is under extensive research in recent years. The significance of these organisms in various metabolic activities inside the body is very crucial. Therefore any alterations in their diversity may results in several fatal diseases and disorders. The efficacy of the classical therapy is consecutively demising with the emergence of tolerance as well as resistance to these therapeutic drugs. Henceforth, a simple, cheaper, receptive and intrinsic means for health benefactor is a vital compulsion of the present era which could be achieved by the means of probiotics. Research have proved that probiotics supplementation against various enteric pathogens has shown promising results with their exceptional ability to compete with pathogenic microbes for various purposes by initiating the activation of specific genes of localized host cells. In the current chapter, the beneficial effect of probiotics consumption in human health and medical sectors has been discussed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Akelma AZ, Topcu ZIK (2016) Probiotics and allergic disease. World J Immunol 6I:75–82
Ammor S, Tauveron G, Dufour E, Chevallier I (2006) Antibacterial activity of lactic acid bacteria against spoilage and pathogenic bacteria isolated from the same meat small-scale facility: screening and characterization of the antibacterial compounds. Food Control 17:454–461
Bakirtzi K, Law IKM, Xue X et al (2016) Neurotensin promotes the development of colitis and intestinal angiogenesis via Hif-1α–miR-210 signaling. J Immunol 196:4311–4321
Barrett HL, Callaway LK, Nitert MD (2012) Probiotics: a potential role in the prevention of gestational diabetes? Acta Diabetol 49:1–13
Barz ML, Anhe FF, Varin TV (2015) Probiotics as complementary treatment for metabolic disorders. Diabetes Metab J 39:291–303
Bongaerts GPA, Severijnen RSVM (2016) A reassessment of the PROPATRIA study and its implications for probiotic therapy. Nat Biotechnol 34:55–63
Cammarota G, Ianiro G, Cianci R et al (2015) The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy. Pharmacol Ther 149:191–212
Cammarota G, Pecere S, Ianiro G et al (2016) Principles of DNA-based gut microbiota assessment and therapeutic efficacy of fecal microbiota transplantation in gastrointestinal diseases. Dig Dis 34:279–285
Chan PA, Robinette A, Montgomery M et al (2016) Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature. Infect Dis Obstet Gynecol 5758387:17
Chen X, Yang G, Song J-H et al (2013) Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation. PLoS One 8:1–7
Curro D, Ianiro G, Pecere S et al (2016) Probiotics, fiber and herbal medicinal products for functional and inflammatory bowel disorders. Brit J Pharmacol 173:61–68
Figueroa-Gonzalez I, Cruz-Guerrero A, Quijano G (2011) The benefits of probiotics on human health. J Microb Biochem Technol S1:003
Fuller R (1989) Probiotics in man and animals. J Appl Bacteriol 66:365–378
Gayathri D, Rashmi BS (2016) Anti-cancer properties of probiotics: a natural strategy for cancer prevention. EC Nutr 5:1191–1202
Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonie microbiota: introducing the concept of prebiotics. J Nutr 125:1401–1412
Gowri RS, Meenambigai P, Prabhavathi P et al (2016) Probiotics and its effects on human health-a review. Int J Curr Microbiol Appl Sci 5:384–392
Hamasalim HJ (2016) Synbiotic as feed additives relating to animal health and performance. Adv Microbiol 6:288–302
Hanson L, Vusse LV, Jerme M et al (2016) Probiotics for treatment and prevention of urogenital infections in women: a systematic review. J Midwifery Womens Health 61:339–355
Hartstra AV, Bouter KEC, Backhed F, Nieuwdorp M (2015) Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care 38:159–165
Hu C, Wong FS, Wen L (2015) Type 1 diabetes and gut microbiota: friend or foe? Pharmacol Res 98:9–15
Iqbal MZ, Qadir MI, Hussain T et al (2014) Probiotics and their beneficial effects against various diseases. Pak J Pharm Sci 27:405–415
Islam SU (2016) Clinical uses of probiotics. Medicine 95:1–5
Kahouli I, Malhotra M, Alaoui-Jamali MA, Prakash S (2015) In-vitro characterization of the anti-cancer activity of the probiotic bacterium Lactobacillus fermentum NCIMB 5221 and potential against colorectal cancer cells. J Cancer Sci Ther 7:224–235
Kang J-H, Yun S-I, Park M-H et al (2013) Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PLoS One 8:1–8
Kareem KY, Ling FH, Chwen LT et al (2014) Inhibitory activity of postbiotic produced by strains of Lactobacillus plantarum using reconstituted media supplemented with inulin. Gut Pathog 6:1–7
Karimi G, Sabran MR, Jamaluddin R et al (2015) The anti-obesity effects of Lactobacillus casei strain shirota versus orlistat on high fat diet-induced obese rats. Food Nutr Res 59:1–8
Kobyliak N, Conte C, Cammarota G et al (2016) Probiotics in prevention and treatment of obesity: a critical view. Nutr Metab 13:1–13
Kristensen NB, Bryrup T, Allin KH et al (2016) Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med 8:1–11
Larsen N, Vogensen FK, vanden Berg FW et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5:1–10
Lewis BB, Buffie CG, Carter R et al (2015) Loss of microbiota-mediated colonization resistance to Clostridium difficile infection is greater following oral vancomycin as compared with metronidazole. J Infect Dis 212:1656–1665
Lilly DM, Stillwell RH (1965) Growth promoting factors produced by probiotics. Science 147:747–748
Ljungberg M, Korpela R, Ilonen J et al (2006) Probiotics for the prevention of beta cell autoimmunity in children at genetic risk of type-1 diabetes-the PRODIA study. Ann N Y Acad Sci 1079:360–364
Mayer EA, Tillisch K, Gupta A (2015) Gut/brain axis and the microbiota. J Clin Invest 125:926–938
Messaoudi M, Lalonde R, Violle N et al (2010) Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 105:755–764
Metchnikoff E, Mitchell PC (1907) Essais optimistes. Heinemann, London
Ooi MF, Mazlan N, Foo HL et al (2015) Effects of carbon and nitrogen sources on bacteriocin-inhibitory activity of postbiotic metabolites produced by Lactobacillus plantarum I-UL4. Malays J Microbiol 11:176–184
Palumbo VD, Marcello R, Gammazza AM et al (2016) The long-term effects of probiotics in the therapy of ulcerative colitis: a clinical study. Biomed Pap 160:372–377
Patel RM, Denning PW (2013) Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence? Clin Perinatol 40:11–25
Perez-Cobas AE, Moya A, Gosalbes MJ, Latorre A (2015) Colonization resistance of the gut microbiota against Clostridium difficile. Antibiotics 4:337–357
Rao AV, Bested AC, Beaulne TM et al (2009) A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 1:1–6
Rao SC, Athalye-Jape GK, Deshpande GC et al (2016) Probiotic supplementation and late-onset sepsis in preterm infants: a meta-analysis. Pediatrics 137:1–16
Shahverdi E (2016) Probiotics and gastrointestinal diseases. Int J Dig Dis 2:1–2
Simova ED, Beshkova DB, Dimitrov P (2009) Characterization and antimicrobial spectrum of bacteriocins produced by lactic acid bacteria isolated from traditional Bulgarian dairy products. J Appl Microbiol 106:692–701
Song S, Lee SJ, Park D-J et al (2016) The anti-allergic activity of Lactobacillus plantarum L67 and its application to yogurt. J Dairy Res 99:9372–9382
Spiller R (2016) Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Research 5:1–11
Takeda S, Hidaka M, Yoshida H et al (2016) Antiallergic activity of probiotics from Mongolian dairy products on type I allergy in mice and mode of antiallergic action. J Funct Foods 9:60–69
Tejero-Sarinena S, Barlow J, Costabile A et al (2013) Antipathogenic activity of probiotics against Salmonella Typhimurium and Clostridium difficile in anaerobic batch culture systems: is it due to synergies in probiotic mixtures or the specificity of single strains? Anaerobe 24:60–65
Tillisch K (2014) The effects of gut microbiota on CNS function in humans. Gut Microbes 5:404–410
Tissier H (1906) Tritement des infections intestinales par la methode de translormation de la flore bacterienne de lintestin. C R Soc Biol 60:359–361 (in French)
Umbrello G, Esposito S (2016) Microbiota and neurologic diseases: potential effects of probiotics. J Transl Med 14:1–11
Vafaeie F (2016) Critical review on probiotics and its effect on cancer. Cancer Press 2:30–34
Vidya S, Thiruneelakandan G (2015) Probiotic potentials of lactobacillus and its anti-cancer activity. Int J Curr Res 7:20680–20684
Waigankar SS, Patel V (2011) Role of probiotics in urogenital healthcare. J Midlife Health 2:5–10
World Health Organization (2017) Cancer fact sheet 2017. World Health Organization, Geneva
Yoo J, Kim S (2016) Probiotics and prebiotics: present status and future perspectives on metabolic disorders. Forum Nutr 8:1–20
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kerry, R.G. et al. (2018). Probiotics: The Ultimate Nutritional Supplement. In: Patra, J., Das, G., Shin, HS. (eds) Microbial Biotechnology. Springer, Singapore. https://doi.org/10.1007/978-981-10-7140-9_7
Download citation
DOI: https://doi.org/10.1007/978-981-10-7140-9_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7139-3
Online ISBN: 978-981-10-7140-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)